Patents by Inventor Monica Bocchia

Monica Bocchia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncogene fusion protein peptide vaccines
    Patent number: 6156316
    Abstract: Fusion-point spanning peptides, for example BCR-ABL fusion breakpoint peptides associated with chronic myelogenous leukemia (CML), bind major histompatibility complex molecules, such as HLA class I molecules, and induce cytotoxic T cell proliferation. The breakpoint peptides can be used as vaccines.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: December 5, 2000
    Assignees: Sloan-Kettering Institute for Cancer Research, Cytel Corporation
    Inventors: David A. Scheinberg, Alessandro Sette, Monica Bocchia